Search | Webyourself Social Media Platform

Sneha CMI added article Other
2024-02-29 11:38:44 -

Transthyretin Amyloid Cardiomyopathy Treatment Market is driven by Increasing Prevalence of ATTR-CM Disease
The global transthyretin amyloid cardiomyopathy treatment market is primarily driven by the increasing prevalence of ATTR-CM disease globally. Transthyretin amyloid cardiomyopathy, also known as ATTR-CM, is a rare, progressive, and frequently life-threatening heart disease caused by abnormal deposits of amyloid protein consisting of misfolded transthyretin (TTR) in the heart. ATTR-CM treatment...

0 Comments 0 Shares 939 Views 0 Reviews

Please log in to like, share and comment!
Pooja Salve added article Health
2023-11-01 05:30:04 -

Emerging Opportunities in Transthyretin Amyloid Cardiomyopathy Treatment Market
The Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market is estimated to be valued at US$ 748.80 million in 2022 and is expected to exhibit a CAGR of 31.1% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights. Market Overview: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive heart muscle disease caused by the buildup...

0 Comments 0 Shares 1408 Views 0 Reviews

Please log in to like, share and comment!
Leena Leena added article Other
2024-06-25 09:19:31 -

Transthyretin Amyloid Cardiomyopathy Treatment Market Driven by Increasing Prevalence of Cardiomyopathy
The Global Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1943.69 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2031.Key players operating in the Transthyretin Amyloid Cardiomyopathy Treatment market are DermaSweep Inc., Lifetrons Switzerland AG, Trophy Skin, Silk€TMn, HoMedics USA LLC, PMD Beauty, Dermaglow,...

0 Comments 0 Shares 523 Views 0 Reviews

Please log in to like, share and comment!